Latest Articles

Publication Date
Giuseppe Caruso: Are all MMRd Endometrial Cancers Really the Same? - Oncodaily

Giuseppe Caruso: Are all MMRd Endometrial Cancers Really the Same? Oncodaily

Published: Feb. 22, 2026, 9:38 a.m.
Multidisciplinary care needed for endometrial cancer: JIPMER - DT Next

Multidisciplinary care needed for endometrial cancer: JIPMER DT Next

Published: Feb. 21, 2026, 3:50 p.m.
Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer - CancerNetwork

Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer CancerNetwork

Published: Feb. 21, 2026, 2:18 p.m.
Comedian Fatiha El-Ghorri, 44, undergoes hysterectomy after being diagnosed with endometrial cancer - MSN

Comedian Fatiha El-Ghorri, 44, undergoes hysterectomy after being diagnosed with endometrial cancer MSN

Published: Feb. 21, 2026, 12:39 p.m.
JIPMER conducts Conference on Endometrial Cancers 2026 - PIB

JIPMER conducts Conference on Endometrial Cancers 2026 PIB

Published: Feb. 21, 2026, 10:05 a.m.
Aprea reports second partial response in endometrial cancer trial By Investing.com - Investing.com South Africa

Aprea reports second partial response in endometrial cancer trial By Investing.com Investing.com South Africa

Published: Feb. 19, 2026, 12:54 a.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria

Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria

Published: Feb. 18, 2026, 11:46 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com

Aprea reports second partial response in endometrial cancer trial Investing.com

Published: Feb. 18, 2026, 1:42 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!